Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet - Reuters

Reuters

Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet Reuters

Lilly to buy Calytrix for up to $1.5 billion in rare blood cancer bet Reuters

Ver fuente original → ← Volver a noticias